Ambient AI Clinical Trial

Part of paid clinical trials in Seattle, Washington.

Sponsor
University of Washington
Study ID
NCT07598721
Status
Completed

Conditions

  • Artificial Intelligence (AI)
  • Physician Burnout
  • Physician Work Environment

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Use of Ambient AI scribe tool on participant's mobile device — OTHER
    Ambient artificial intelligence (AI) scribes are a clinical documentation tool that uses automated speech recognition and large-scale language models to capture and transcribe synchronous patient-provider encounters in real time. Clinicians then review, edit, and authorize the AI-generated text before finalizing the chart, ensuring necessary human oversight and medical accuracy. In this study, participants used Ambient AI scribes on mobile devices for the recordings. The ambient AI scribe will be available for the provider to use in the outpatient setting. They were not required to use the Ambient AI scribe, but could choose whether to use it and with which patients. Consent to use the device was documented for all patient encounters.

Study Details

This is a single-site pragmatic randomized control trial studying the effect of ambient artificial intelligence (AI) scribes on the delivery of medical care to patients in the ambulatory setting. The study will last 150 days and include up to 65 providers in the intervention group. Providers will be recruited from three medical specialties, including primary care, oncology, and urology. The study will enroll providers and randomize them to an intervention group (access to the ambient AI scribe product) or a control group (routine patient care). Providers will be evaluated for burnout and task load measures through digital surveys at the beginning, middle, and end of the study. Provider electronic health record (EHR) usage data will also be evaluated for time spent documenting, time spent after hours on days with scheduled clinical care, and time between the start of the clinical encounter and signing it.

Key Dates

Start date
Dec 19, 2024
Status verified
May 2026
Primary completion
Jul 4, 2025
Completion
Jul 4, 2025

Study Design

Enrollment
139 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH

Arms

  • Experimental: Ambient AI scribe users
    Participants in this arm will utilize the ambient AI scribe tools from Abridge. They will otherwise continue their usual clinical activities, including providing care with trainees (e.g., medical students, residents) and multiple family members in the room. The tool will be used exclusively in the outpatient clinical setting and only when the participant is present. The ambient AI scribe tool integrates into the electronic health record (EHR), and the EHR's mobile app is used to collect the recording on a mobile device. The ambient AI scribe tool is transcriptional and does not provide clinical decision support.
  • No Intervention: Routine patient care (no AI scribe)
    These participants were not provided with the ambient AI scribe application on their mobile device. They still had access to documentation with dictation or existing scribe services (non-AI).

Primary Outcome Measure

Professional Fulfillment Index (PFI) [ Time Frame: Surveyed at enrollment (day 0 of pilot), midpoint (day 75), and end of pilot (day 150) ]

Locations (1)

FacilityCityStateZIPSite coordinators
University of Washington Medical CenterSeattleWashington98195-

Find similar trials in Seattle, WA

By research site
University of Washington Medical Center· Seattle, WA

Related Studies